Watts Gwilliam & Co., LLC Pds Biotechnology Corp Transaction History
Watts Gwilliam & Co., LLC
- $569 Million
- Q2 2025
A detailed history of Watts Gwilliam & Co., LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Watts Gwilliam & Co., LLC holds 55,000 shares of PDSB stock, worth $53,350. This represents 0.01% of its overall portfolio holdings.
Number of Shares
55,000Holding current value
$53,350% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
58Shares Held
7.69MCall Options Held
98.2KPut Options Held
0-
Armistice Capital, LLC New York, NY2.24MShares$2.17 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.89 Million0.0% of portfolio
-
Ubs Group Ag543KShares$526,7300.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$472,3570.0% of portfolio
-
Geode Capital Management, LLC Boston, MA418KShares$405,3950.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $27.6M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...